Showing all 3 results
Significant Weight Reduction: Clinical trials indicate that participants on high-dose retatrutide lost an average of 17.5% of their body weight at 24 weeks, with reductions reaching over 24% at 48 weeks. Triple-Hormone Mechanism: Unlike semaglutide (GLP-1) or tirzepatide (GLP-1/GIP), retatrutide adds glucagon receptor agonism, which increases energy expenditure and helps burn more fat. Improved Metabolic…
Significant Weight Reduction: Clinical trials indicate that participants on high-dose retatrutide lost an average of 17.5% of their body weight at 24 weeks, with reductions reaching over 24% at 48 weeks. Triple-Hormone Mechanism: Unlike semaglutide (GLP-1) or tirzepatide (GLP-1/GIP), retatrutide adds glucagon receptor agonism, which increases energy expenditure and helps burn more fat. Improved Metabolic…
Significant Weight Reduction: Clinical trials indicate that participants on high-dose retatrutide lost an average of 17.5% of their body weight at 24 weeks, with reductions reaching over 24% at 48 weeks. Triple-Hormone Mechanism: Unlike semaglutide (GLP-1) or tirzepatide (GLP-1/GIP), retatrutide adds glucagon receptor agonism, which increases energy expenditure and helps burn more fat. Improved Metabolic…
End of content
End of content
No items in your cart. Go on, fill it up with something you love!
Start Shopping Now